[Clinical application of the new action of macrolide preparations to respiratory diseases].
Mikasa
K
K
Furunishi
M
M
Maeda
K
K
Sakamoto
M
M
Ueta
K
K
Mashima
T
T
Kita
E
E
Narita
N
N
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy*; D002908:Chronic Disease; D017291:Clarithromycin / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D004917:Erythromycin; D017291:Clarithromycin